Study of Cemiplimab in Adults With Cervical Cancer
Public ClinicalTrials.gov record NCT03257267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Carcinoma
Study identification
- NCT ID
- NCT03257267
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 608 participants
Conditions and interventions
Conditions
Interventions
- Cemiplimab Drug
- Investigator Choice (IC) Chemotherapy Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 4, 2017
- Primary completion
- Mar 14, 2021
- Completion
- Apr 19, 2023
- Last update posted
- Apr 7, 2025
2017 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates | Phoenix | Arizona | 85016 | — |
| Arizona Oncology Associates | Tucson | Arizona | 85711 | — |
| University of California Irvine | Orange | California | 92868 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Cancer Research for the Ozarks | Springfield | Missouri | 65804 | — |
| New York Presbyterian Queens | Flushing | New York | 11355 | — |
| Northwell Health | Lake Success | New York | 11042 | — |
| Laura and Issac Perlmutter Cancer Center at NYU Langone | New York | New York | 10016 | — |
| First Health of the Carolinas Outpatient Cancer Center | Pinehurst | North Carolina | 28374 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Texas Oncology, P.A. | Austin | Texas | 78745 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03257267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2025 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03257267 live on ClinicalTrials.gov.